{"id":210,"date":"2020-12-08T13:39:18","date_gmt":"2020-12-08T18:39:18","guid":{"rendered":"https:\/\/sites.bu.edu\/melodem\/?page_id=210"},"modified":"2026-03-09T16:37:02","modified_gmt":"2026-03-09T20:37:02","slug":"recordings","status":"publish","type":"page","link":"https:\/\/sites.bu.edu\/melodem\/resources\/recordings\/","title":{"rendered":"Recordings"},"content":{"rendered":"

2026<\/h3>
<\/p>\n

February 19th, 2026: <\/strong>Bryan James & Ali Moghtaderi, “Predictors and consequences of the timing and accuracy of clinical dementia diagnosis”<\/a><\/p>\n

March 5th, 2026: <\/strong>Aaron Scheffler, “Bayesian Inference for Alzheimer’s Disease Progression Models – Promises and Challenges in Uncertainty Propagation”<\/span><\/a><\/p>\n

<\/div>\n<\/div>\n\n

2025<\/h3>
<\/p>\n

May 15th, 2025:<\/strong> Calvin Colvin, “The relationship between income trajectory during prime working years with cognition in later life using data from the Health and Retirement Study.”<\/a><\/p>\n

May 1st, 2025:<\/strong> Sarah Farias, “The measurement of everyday function in older adults.“<\/span><\/a><\/p>\n

April 17th, 2025:\u00a0<\/strong>Timothy Daly, “Opportunities and Challenges for Public Brain Health”<\/a><\/p>\n

April 3rd, 2025:\u00a0<\/strong>Natalia Gomes Goncalves, “Cognitive Reserve in Latin America: Evidence from Mexico and Brazil”<\/a><\/p>\n

February 20th, 2025: <\/strong>Renaud La Joie & Ganna Blazhenets, “Harmonization of amyloid-PET quantification for ADRD research: putting Centiloids to the test”<\/a><\/p>\n

See Slides: Part 1<\/a> & Part 2<\/a><\/p>\n

February 6th, 2025<\/strong>: Sebastian Walsh, “The value of a population-level lens in dementia research: examples from prevention and treatment”\u00a0<\/span><\/a><\/p>\n

See Slides<\/a><\/p>\n

January 16th, 2025: <\/strong>Miguel Arce and Emily Brice\u00f1o-Abreu, “Cross-national harmonization of the Harmonized Cognitive Assessment Protocol (HCAP)”<\/a><\/p>\n

<\/div>\n<\/div>\n\n

2024<\/h3>
<\/p>\n

November 21st, 2024:<\/strong> Yingyan Wu, “How to assess cognitive decline when test administration changes across study waves? Harmonizing cognitive scores across waves in CHARLS”<\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

October 17th, 2024:<\/strong> Mary Thoma, “Are we there yet? <\/span>Estimating the waves of follow-up required for stable estimates in cognitive aging research”<\/span><\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

October 3rd, 2024:<\/strong> Dr. Vijaya Kolachalama, “Multimodal machine learning for differential dementia diagnosis”<\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

September 19th, 2024:<\/strong> Dr. Roopal Desai & Dr. Verena Zuber, “Examining the Lancet Commission on risk factors for dementia using Mendelian Randomization”<\/a><\/p>\n

See Slides<\/a><\/p>\n

September 5th, 2024:<\/strong> Dr. Phil Cantu, “Differential Item Functioning of informant measures of cognitive functioning in the U.S. and Mexico”<\/a><\/span><\/p>\n

May 16th, 2024:<\/strong> Dr. Gabriel L. Schwartz, “Housing insecurity, foreclosure, and cognitive aging”<\/a><\/p>\n

See Slides<\/a><\/p>\n

April 18th, 2024: <\/strong>Dr. Byron Jaeger, “Oblique and causal random forests”<\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

March 21st, 2024:<\/strong> Dr. Erin Ferguson, “Robustness of effect estimates to varying model specifications”<\/a><\/p>\n

See Slides<\/a><\/p>\n

March 7th, 2024:<\/strong> Dr. Joan Monin, “Systolic Blood Pressure During Conversations between Older Adults Living with Cognitive Impairment and their Children: Associations with Attachment Security”<\/a><\/p>\n

See Slides<\/a><\/p>\n

February 29th, 2024:<\/strong> Dr. Eleanor Hayes-Larson, \u201cImplications of timescale choice for estimated effects of exposures on rate of cognitive change among older adults: Results from the 2022 MELODEM Data Workshop\u201d<\/a><\/p>\n

See Slides<\/a><\/p>\n

February 1st, 2024:\u00a0<\/strong> DEBATE<\/a>, Dr. David Wallon, “Are anti-amyloid immunotherapies’disease modifying’ or symptomatic treatments for Alzheimer’s disease?” & Dr. Vincent Planche “Are anti-amyloid immunotherapies disease-modifying or symptomatic treatment for early AD?”<\/p>\n

See Slides: David Wallon Slides<\/a> & Vincent Planche\u00a0Slides<\/a><\/p>\n

January 18th, 2024:<\/strong>\u00a0 Dr. Maria Glymour, “Evidence Triangulation and Dementia Research”<\/a><\/p>\n

See Slides<\/a><\/p>\n

<\/div>\n<\/div>\n\n

2023<\/h3>
<\/p>\n

December 14th, 2023:<\/strong> Dr. Rachel Whitmer, “Launching Cohort Studies within Integrated Healthcare Delivery Systems Vs Communities: Opportunities for Life-course Epidemiology”<\/a><\/p>\n

November 30th, 2023:<\/strong> Dr. Zachary Kunicki, \u201cUnderstanding Normative Cognitive Aging\u201d<\/a><\/p>\n

See Slides<\/a><\/p>\n

November 16th, 2023:<\/strong>\u00a0 Dr. Carole Dufouil, “The MEMENTO Cohort: Update on Data Availability Access Procedures”<\/a><\/p>\n

October 19th, 2023:<\/strong> Dr. Aayush Khadka, “Quantile regressions for quantifying heterogeneities in the education-cognition relationship”<\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

October 5th, 2023:<\/strong> Dr. Paloma Rojas-Saunero, “Effect of incident stroke on the risk of dementia over a period of 10 years of follow-up in a cohort of Asian American and white older adults in California”\u00a0<\/span><\/a><\/p>\n

See Slides<\/span><\/a><\/p>\n

September 21st, 2023:<\/strong> Dr. Suzanne Judd, “REGARDS and RURAL – Cohorts for Potential Dementia Questions” & “Cognitive Impairment in REGARDS”<\/span><\/a><\/p>\n

See Slides: Slide deck 1<\/a> & Slide deck 2<\/a><\/p>\n

April 20th, 2023:<\/strong> Dr. Jennifer J. Manly, \u201cMethods for Estimating National Prevalence of Dementia and MCI from the Harmonized Cognitive Assessment Protocol Project\u201d<\/a><\/p>\n

See Slides<\/a><\/p>\n

April 6th, 2023:<\/strong> Dr. Maude Wagner, “Using Longitudinal Continuous Measures to Capture Key Complementary Dimensions of Cognitive Resilience to AD Neuropathology”<\/a><\/span><\/p>\n

See Slides<\/a><\/p>\n

March 16th, 2023:<\/strong> Dr. Roch A. Nianogo, “Risk Factors Associated with Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US”<\/a><\/p>\n

See Slides<\/a><\/p>\n

March 2nd, 2023:<\/strong> Dr. Lon S. Schneider, “Lecanemab: effectiveness, approval, and why it takes a village”<\/a><\/p>\n

See Slides<\/a><\/p>\n

February 16th, 2023:<\/strong> Dr. Terry M Therneau, “Competing risks and the Fine-Gray model”<\/a><\/p>\n

See Slides<\/a><\/p>\n

February 2nd, 2023:<\/strong> Dr. Erin E. Bennett, “Methodological considerations in target trial emulation using cohort studies: estimating the effect of antihypertensive medication initiation on incident dementia in ARIC, CHS, and HRS”<\/a><\/p>\n

See Slides<\/a><\/p>\n

January 19th, 2023:<\/strong> Dr. Marina Sirota, “Leveraging Molecular and Clinical Data to Better Understand Alzheimer\u2019s Disease”<\/a><\/p>\n

See Slides<\/a><\/p>\n

<\/div>\n<\/div>\n\n

2022<\/h3>
<\/p>\n

December 15th, 2022:<\/strong> Dr. Sepideh Modrek, & Dr. David Rehkopf, “Long-term effects of Local Area New Deal Work-Relief in Childhood on Educational and Cognitive Outcomes over the Life Course”<\/a><\/p>\n

See Slides<\/a><\/p>\n

December 1st, 2022:<\/strong> Dr. Tara E. Jenson, “Environmental Cadmium Exposures, Cognitive Performance in Older Adults, and Subsequent Alzheimer’s Disease Mortality”<\/a><\/p>\n

See Slides<\/a><\/p>\n

November 3rd, 2022:<\/strong> Dr. Tianhao Wang, “The ‘cognitive clock’: A novel indicator of brain health”<\/a><\/p>\n

See Slides<\/a><\/p>\n

October 20th, 2022:<\/strong> Dr. Emma Nichols, “The\u00a0<\/span>use of algorithms for the identification of incident dementia: challenges and potential biases”<\/span><\/a><\/p>\n

See Slides<\/a><\/p>\n

October 6th, 2022:<\/strong> Dr. John (Rob) Warren, “High School & Beyond: Turning an Education Cohort Study into an ADRD Study”<\/span><\/a><\/p>\n

See Slides<\/a><\/p>\n

September 15th, 2022:<\/strong> Dr. Marcia P Jimenez & Dr. L. Paloma Rojas-Saunero, \u201cRacial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis<\/span>\u201d<\/a><\/p>\n

See Slides<\/a><\/p>\n

<\/div>\n<\/div>\n\n

2021<\/h3>
<\/p>\n

November 18th, 2021:<\/strong> Dr. Madhav Thambisetty, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer\u2019s cure”<\/a><\/p>\n

See Slides<\/a><\/p>\n

October 28th, 2021:<\/strong> Dr. Venexia Walker, “Predicting drug repurposing opportun<\/span>i<\/span>ties <\/span>for Alzheimer\u2019s disease prevention <\/span>using genome-wide association study data”<\/span><\/a><\/p>\n

See Slides<\/a><\/p>\n

October 8th, 2021:<\/strong> Dr. Maria Glymour, “Introduction to using Directed Acyclic Graphs in dementia research”<\/a><\/p>\n

See Slides<\/a><\/p>\n

July 15th, 2021:<\/strong> Dr. Thomas Nedelec, “Data-driven identification of health conditions associated with incident Alzheimer\u2019s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”<\/a><\/p>\n

See Slides<\/a><\/p>\n

April 29th, 2021:<\/strong> “Re-orienting to MELODEM”<\/p>\n

Re-orienting to MELODEM<\/a><\/p>\n

April 1st, 2021:<\/strong> Dr. Zach Baucom, “Using State Space Models for Longitudinal Neuropsychological Outcomes”<\/a><\/p>\n

See Slides<\/a><\/p>\n

March 18th, 2021:<\/strong> Dr. Lon Schneider, “Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development”<\/a><\/p>\n

See Slides<\/a><\/p>\n

March 4th, 2021:<\/strong> Dr. Terry Therneau, \u201cMulti-state survival models and dementia\u201d<\/span><\/a><\/p>\n

February 18th, 2021:<\/strong> Dr. Andrew Stokes, “Estimations of the Association of Dementia with US Mortality Levels Using Linked Survey and Mortality Records”<\/a><\/p>\n

February 11th, 2021:<\/strong> Dr. Julie Zissimopoulos, “Drug therapies for chronic conditions and risk of ADRD:\u00a0 analyses using claims data”<\/span><\/a><\/p>\n

February 4th, 2021:<\/strong> Dr. Justina Avila-Rieger, “Using Multilevel Analysis of Individual Heterogeneity & Discriminatory Accuracy (MAIHDA) to Examine Intersectional Inequalities in Cognitive Aging”<\/span><\/a><\/p>\n

<\/div>\n<\/div>\n\n

2020<\/h3>
<\/p>\n

December 10th, 2020:<\/strong> Dr. Maria Corrada & Dr. Sevil Yasar, “Statin Use, Hx of High Cholesterol & Risk of Dementia in the Oldest-old: illustration of challenges when analyzing pharmacoepidemiological data”<\/span><\/a><\/p>\n

December 3rd, 2020:<\/strong> Dr. Eric Tchetgen Tchetgen, \u201cMR GENIUS: A Principled Approach to Robust Mendelian Randomization Interference\u201d<\/span><\/a><\/p>\n

July 9th, 2020:<\/strong> Dr. Bryan James, “Implications of covid for dementia researchers”<\/a><\/p>\n

See Slides<\/a><\/p>\n

<\/div>\n<\/div>\n\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

   <\/p>\n","protected":false},"author":18606,"featured_media":0,"parent":464,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"page-templates\/no-sidebars.php","meta":[],"_links":{"self":[{"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/pages\/210"}],"collection":[{"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/users\/18606"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/comments?post=210"}],"version-history":[{"count":52,"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/pages\/210\/revisions"}],"predecessor-version":[{"id":1291,"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/pages\/210\/revisions\/1291"}],"up":[{"embeddable":true,"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/pages\/464"}],"wp:attachment":[{"href":"https:\/\/sites.bu.edu\/melodem\/wp-json\/wp\/v2\/media?parent=210"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}